Adults With Psoriasis More Likely to Have Rheumatoid Arthritis
THURSDAY, June 24, 2021 -- Adults with psoriasis have an increased likelihood of having rheumatoid arthritis (RA) compared with adults without psoriasis, according to a study published online June 15 in the Journal of the American Academy of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 24, 2021 Category: Pharmaceuticals Source Type: news

Switching from Western diet to a balanced diet may reduce skin, joint inflammation
(University of California - Davis Health) Diet rich in sugar and fat leads to disruption in the gut's microbial culture and contributes to inflammatory skin diseases such as psoriasis. Research shows that switching to a more balanced diet restores the gut's health and suppresses inflammation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2021 Category: International Medicine & Public Health Source Type: news

Psoriasis and Body Image
People with psoriasis share their experiences and how they learned to manage issues with body image, self-esteem, and quality of life. (Source: WebMD Health)
Source: WebMD Health - June 18, 2021 Category: Consumer Health News Source Type: news

Photobiomodulation: Evaluation in Various Specialties Underway Photobiomodulation: Evaluation in Various Specialties Underway
The therapy is used to treat a wide variety disorders including acne vulgaris, psoriasis, burns, wound healing, and oral mucositis associated with cancer treatment.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - June 18, 2021 Category: Dermatology Tags: Dermatology News Source Type: news

Getting Biologics for Psoriasis: What You Need to Know
Biologic therapy is a breakthrough treatment for psoriasis, but what do you need to know before you try it? One woman shares the ups and downs of her biologics treatment journey. (Source: WebMD Health)
Source: WebMD Health - June 18, 2021 Category: Consumer Health News Source Type: news

Higher BMI Linked to Increased Risk for Developing Psoriasis
WEDNESDAY, June 16, 2021 -- Higher body mass index (BMI) seems to be associated with an increased risk for developing psoriasis, according to a study published online June 9 in the Journal of the American Academy of Dermatology. Alexandra Norden,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 16, 2021 Category: Pharmaceuticals Source Type: news

Living Day to Day With Psoriasis
Lifestyle changes can help improve your psoriasis and your overall health. Follow these expert tips. (Source: WebMD Health)
Source: WebMD Health - June 14, 2021 Category: Consumer Health News Source Type: news

Psoriasis Treatment With Biologics: 5 Things to Know Psoriasis Treatment With Biologics: 5 Things to Know
With a number of these agents available and another pending FDA approval, determining the right drug for your patients may be challenging. Start with these key facts.Medscape Dermatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 14, 2021 Category: Consumer Health News Tags: Dermatology Commentary Source Type: news

Psoriasis: Tips for Wearing Makeup
Some people with psoriasis choose to use makeup. Since this condition can cause skin flakiness and sensitivity, it’s important to be careful when applying makeup. Find out which products to use, what to avoid, and how to use and remove makeup with psoriasis. (Source: WebMD Health)
Source: WebMD Health - June 8, 2021 Category: Consumer Health News Source Type: news

Are Psoriasis and Allergies Linked?
Psoriasis and allergies both cause itchy, skin and both involve immune system reactions. Could they be related? (Source: WebMD Health)
Source: WebMD Health - June 5, 2021 Category: Consumer Health News Source Type: news

Getting Biologics for Psoriasis: What You Need to Know
Biologic therapy is a breakthrough treatment for psoriasis, but what do you need to know before you try it? One woman shares the ups and downs of her biologics treatment journey. (Source: WebMD Health)
Source: WebMD Health - June 4, 2021 Category: Consumer Health News Source Type: news

Dermavant Submits New Drug Application (NDA) to FDA for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis
LONG BEACH, Calif., and BASEL, Switzerland, June 3, 2021—Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that it has... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 3, 2021 Category: Drugs & Pharmacology Source Type: news

Secukinumab, IL-17 Inhibitor, Approved for Pediatric Psoriasis Secukinumab, IL-17 Inhibitor, Approved for Pediatric Psoriasis
' This has changed the playing field for these children and their families completely, ' said one pediatric dermatologist at the University of California San Francisco.FDA Approvals (Source: Medscape Pediatrics Headlines)
Source: Medscape Pediatrics Headlines - June 2, 2021 Category: Pediatrics Tags: Dermatology News Alert Source Type: news

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA ® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)
SPRING HOUSE, PENNSYLVANIA, June 2, 2021 – Today the Janssen Pharmaceutical Companies of Johnson & Johnson announced new efficacy and safety data for first-in-class TREMFYA® (guselkumab), including data from the first study evaluating a selective IL-23 inhibitor in adult patients with active PsA, all of whom had demonstrated inadequate response or intolerance to TNFi.1 In the COSMOS Phase 3b study, significantly higher proportions of patients treated with TREMFYA showed joint symptom improvement and complete skin clearance versus placebo at week 24 in this true TNFi-IRa patient population, which is often more diffic...
Source: Johnson and Johnson - June 2, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Novartis Cosentyx Receives FDA Approval for Treatment of Children and Adolescents with Moderate to Severe Plaque Psoriasis
EAST HANOVER, N.J., June 1, 2021 /PRNewswire/ -- Novartis, a leader in immuno-dermatology and rheumatology, today announced the U.S. Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) for the treatment of moderate to severe... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - June 1, 2021 Category: Drugs & Pharmacology Source Type: news